Icon

QUESTRAN (nda016640)- (EQ 4GM RESIN/PACKET,EQ 4GM RESIN/SCOOPFUL)

CHOLESTYRAMINE BRISTOL MYERS
EQ 4GM RESIN/PACKET,EQ 4GM RESIN/SCOOPFUL
No No
Expired Expired
None None
None No
QUESTRAN (Cholestyramine for Oral Suspension USP), is indicated as adjunctive therapy to diet for the reduction of elevated serum cholesterol in patients with primary hypercholesterolemia (elevated low density lipoprotein [LDL] cholesterol) who do not respond adequately to diet. QUESTRAN may be useful to lower LDL cholesterol in patients who also have hypertriglyceridemia, but it is not indicated where hypertriglyceridemia is the abnormality of most concern.
18 0 13
Total Other Developers 2
Drugs with Suitability No
EQ 4GM RESIN/PACKET ** ** - - 10
EQ 4GM RESIN/SCOOPFUL ** ** - 1 10
NDA Sales Available Total Generic Sales Available
No 12
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ****** ***** **** ******-***** ************, *** *********** ***** **** *** *, ********, ********* (**) *****-****, ****** ****** (***) ***
****** **** ****** *** **** ******, *** *********** ***** ***** ******* ******, *********, *** **** (**) *****, ****** ****** (***) ***
****** **** ****** *** **** ******, *** *********** ***** ***** ******* ******, *********, *** **** (**) *****, ****** ****** (***) ***
****** **** ************ ***** ** *********** ***** ********* ((** ********** ***** ****)) **, *************, ********* *****, ***** (***) ***
****** **** ************ ***** ** *********** ***** ********* ((** ********** ***** ****)) **, *************, ********* *****, ***** (***) ***
****** ****** ****** *** ****** ****** ******* *********** **** **. *-*** /* ***** *** - **** **, *******, ******* ******, ***** (***) ***
****** ***** **** *** ***** ************ ******* *********** ****** ** ****, ****, ****, **** ******* *****, ****** ********, *****, ******** ******* ******, ***** (***) ***
****** ***** **** *** ***** ************ ******* *********** ****** ** ****, ****, ****, **** ******* *****, ****** ********, *****, ******** ******* ******, ***** (***) ***
****** ****** ***** **** ******-***** ************, *** *********** ***** **** *** *, ********, ********* (**) *****-****, ****** ****** (***) ***
****** *** ****** *** *************** ******, ***. *********** *** ******** ***** ****, ********, ** *** ***, ****** (***) ***
****** **** ********** *** ************ ******* ******* *********** */***, **********-******** **** ****, **********, ***********,,, *******, ***** **** ******, ***** (***) ***
****** **** ********** *** ************ ******* ******* *********** */***, **********-******** **** ****, **********, ***********,,, *******, ***** **** ******, ***** (***) ***
****** ***** ****** ***** ************ ******* *********** ******* ****** *****, *.*. *****, ******-********, *****, ******** ******* ******, ***** (***) ***
****** ***** ****** ***** ************ ******* *********** ******* ****** *****, *.*. *****, ******-********, *****, ******** ******* ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.